171 related articles for article (PubMed ID: 11904239)
1. The costs of epilepsy in Italy: a prospective cost-of-illness study in referral patients with disease of different severity.
Tetto A; Manzoni P; Millul A; Beghi E; Garattini L; Tartara A; Avanzini G;
Epilepsy Res; 2002 Feb; 48(3):207-16. PubMed ID: 11904239
[TBL] [Abstract][Full Text] [Related]
2. Direct cost of medical management of epilepsy among adults in Italy: a prospective cost-of-illness study (EPICOS).
Beghi E; Garattini L; Ricci E; Cornago D; Parazzini F;
Epilepsia; 2004 Feb; 45(2):171-8. PubMed ID: 14738425
[TBL] [Abstract][Full Text] [Related]
3. The costs of childhood epilepsy in Italy: comparative findings from three health care settings.
Guerrini R; Battini R; Ferrari AR; Veggiotti P; Besana D; Gobbi G; Pezzani M; Berta E; Tetto A; Beghi E; Monticelli ML; Tediosi F; Garattini L; Russo S; Rasmini P; Amadi A; Quarti P; Fabrizzi R;
Epilepsia; 2001 May; 42(5):641-6. PubMed ID: 11380572
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy.
Luoni C; Canevini MP; Capovilla G; De Sarro G; Galimberti CA; Gatti G; Guerrini R; La Neve A; Mazzucchelli I; Rosati E; Specchio LM; Striano S; Tinuper P; Perucca E
Epilepsia; 2015 Jul; 56(7):1162-73. PubMed ID: 26046371
[TBL] [Abstract][Full Text] [Related]
5. A review of the costs of managing childhood epilepsy.
Beghi E; Frigeni B; Beghi M; De Compadri P; Garattini L
Pharmacoeconomics; 2005; 23(1):27-45. PubMed ID: 15693726
[TBL] [Abstract][Full Text] [Related]
6. Side-effects of antiepileptic drugs: the economic burden.
de Kinderen RJ; Evers SM; Rinkens R; Postulart D; Vader CI; Majoie MH; Aldenkamp AP
Seizure; 2014 Mar; 23(3):184-90. PubMed ID: 24315662
[TBL] [Abstract][Full Text] [Related]
7. The direct costs of epilepsy in Russia. A prospective cost-of-illness study from a single center in Moscow.
Guekht A; Mizinova M; Kaimovsky I; Danilenko O; Bianchi E; Beghi E
Epilepsy Behav; 2016 Nov; 64(Pt A):122-126. PubMed ID: 27736658
[TBL] [Abstract][Full Text] [Related]
8. Direct medical cost of children and adolescents epilepsy at a university setting in Croatia.
Prpić I; Boban M; Skarpa-Prpić I; Jurjević A; Babić T; Fiket D
Coll Antropol; 2009 Jun; 33(2):503-8. PubMed ID: 19662770
[TBL] [Abstract][Full Text] [Related]
9. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany.
Strzelczyk A; Haag A; Reese JP; Nickolay T; Oertel WH; Dodel R; Knake S; Rosenow F; Hamer HM
Epilepsy Behav; 2013 Jun; 27(3):433-8. PubMed ID: 23591262
[TBL] [Abstract][Full Text] [Related]
10. Direct medical costs of refractory epilepsy incurred by three different treatment modalities: a prospective assessment.
Boon P; D'Havé M; Van Walleghem P; Michielsen G; Vonck K; Caemaert J; De Reuck J
Epilepsia; 2002 Jan; 43(1):96-102. PubMed ID: 11879393
[TBL] [Abstract][Full Text] [Related]
11. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany.
Hamer HM; Spottke A; Aletsee C; Knake S; Reis J; Strzelczyk A; Oertel WH; Rosenow F; Dodel R
Epilepsia; 2006 Dec; 47(12):2165-72. PubMed ID: 17201718
[TBL] [Abstract][Full Text] [Related]
12. Profile of antiepileptic pharmacotherapy in a tertiary referral center in South India: a pharmacoepidemiologic and pharmacoeconomic study.
Radhakrishnan K; Nayak SD; Kumar SP; Sarma PS
Epilepsia; 1999 Feb; 40(2):179-85. PubMed ID: 9952264
[TBL] [Abstract][Full Text] [Related]
13. Cost-of-illness of epilepsy in Italy. Data from a multicentre observational study (Episcreen).
Berto P; Tinuper P; Viaggi S
Pharmacoeconomics; 2000 Feb; 17(2):197-208. PubMed ID: 10947342
[TBL] [Abstract][Full Text] [Related]
14. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D
Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
[TBL] [Abstract][Full Text] [Related]
15. Use and costs of concomitant medicines in epileptic patients in Poland: a 12-month prospective multicentre study.
Majkowska-Zwolińska B; Jędrzejczak J; Majkowski J
Seizure; 2011 Nov; 20(9):673-8. PubMed ID: 21757378
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of costs of epilepsy using an electronic practice management software in Germany.
Noda AH; Hermsen A; Berkenfeld R; Dennig D; Endrass G; Kaltofen J; Safavi A; Wiehler S; Carl G; Meier U; Elger CE; Menzler K; Knake S; Rosenow F; Strzelczyk A
Seizure; 2015 Mar; 26():49-55. PubMed ID: 25799902
[TBL] [Abstract][Full Text] [Related]
17. [Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy--preliminary results].
Picot MC; Neveu D; Kahane P; Crespel A; Gélisse P; Hirsch E; Derambure P; Dupont S; Landré E; Chassoux F; Valton L; Vignal JP; Marchal C; Rougier A; Lamy C; Semah F; Biraben A; Arzimanoglou A; Petit J; Thomas P; Dujols P; Ryvlin P
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S354-67. PubMed ID: 15331984
[TBL] [Abstract][Full Text] [Related]
18. Antiepileptic Drug Titration and Related Health Care Resource Use and Costs.
Fishman J; Kalilani L; Song Y; Swallow E; Wild I
J Manag Care Spec Pharm; 2018 Sep; 24(9):929-938. PubMed ID: 29486142
[TBL] [Abstract][Full Text] [Related]
19. Uptake and costs of care for epilepsy: findings from a U.K. regional study.
Jacoby A; Buck D; Baker G; McNamee P; Graham-Jones S; Chadwick D
Epilepsia; 1998 Jul; 39(7):776-86. PubMed ID: 9670907
[TBL] [Abstract][Full Text] [Related]
20. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
Arzimanoglou A; Kulak I; Bidaut-Mazel C; Baldy-Moulinier M
Rev Neurol (Paris); 2001 May; 157(5):525-36. PubMed ID: 11438772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
